SCHEMBL2179600

SCHEMBL2179600

Cn1c(=O)c2nc(CNCCCN3CCOCC3)nnc2n(-c2ccc(F)cc2)c1=O

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.44
HSD17B10 Q99714 4/20 0.44
CASP1 P29466 1/20 0.44
CASP7 P55210 1/20 0.44
POLB P06746 1/20 0.43
CYP3A4 P08684 2/20 0.41
CYP2C19 P33261 2/20 0.41
CYP2D6 P10635 1/20 0.41
TSHR P16473 4/20 0.40
KDM4E B2RXH2 4/20 0.40
MAPK1 P28482 3/20 0.40
HPGD P15428 3/20 0.40
USP2 O75604 1/20 0.40
GAA P10253 1/20 0.40
TP53 P04637 2/20 0.40
MEN1 O00255 1/20 0.39
KMT2A Q03164 1/20 0.39
CACNA1G O43497 1/20 0.38
PDE5A O76074 1/20 0.38
HTT P42858 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2181923 0.95 HSD17B10 (0.45) ALDH1A1HSD17B10CASP1CASP7POLB
SCHEMBL2181518 0.91 SCN5A (0.42) ALDH1A1HSD17B10CYP3A4TSHRKDM4E
SCHEMBL2183385 0.86 POLB (0.48) ALDH1A1HSD17B10CASP1CASP7POLB
SCHEMBL2181996 0.86 SIGMAR1 (0.41) ALDH1A1HSD17B10CASP1CASP7CYP3A4
SCHEMBL2183693 0.85 TSHR (0.49) ALDH1A1HSD17B10CASP1CASP7CYP2D6
SCHEMBL2182311 0.85 DCTPP1 (0.35) HSD17B10POLBTSHRTP53HTT
SCHEMBL3262395 0.84 DCTPP1 (0.34) HSD17B10POLBTSHRTP53HTT
SCHEMBL2182871 0.84 DCTPP1 (0.34) HSD17B10POLBTSHRTP53HTT
SCHEMBL2180739 0.84 POLB (0.53) ALDH1A1HSD17B10POLBCYP3A4CYP2C19
SCHEMBL2181237 0.83 HSD17B10 (0.47) ALDH1A1HSD17B10CASP1CASP7POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110166144-A1 Pyrimidotriazinediones and Pyrimidopyrimidinediones and Methods of Using the Same THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) 2011-07-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110166144-A1 Pyrimidotriazinediones and Pyrimidopyrimidinediones and Methods of Using the Same DPYD, TYMP, DHFR ALDH1A1 245/4885HSD17B10 962/4885CASP1 2584/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.